Acetylsalicylic acid has no effects on various isolated immune cells in vitro

  • G. Uhlenbruck
  • H. Lötzerich
  • J. Bernhardt
  • K. Rogalla
Article

Summary

In addition to the well known biological effects of acetylsalicylic acid (ASA), its stimulating effect on the immune system has recently been described. In the present study, therefore, the influence of ASA on isolated leucocytes was investigated in vitro. Various concentrations of ASA, representing therapeutic concentrations, had neither an inhibitory nor a stimulating influence on the cytotoxicity of C1316-positive cells. The phytohaemagglutinin-induced proliferation of lymphocytes and the phagocytosis activity of monocytes and neutrophilic granulocytes was similarly unaffected. These results would indicate that the immunostimulating effects already described for ASA cannot be examined in isolated leucocytes in vitro and should be attributed to an interaction of various effector cells in vivo.

Key words

Acetylsalicylic acid Phagocytes Natural killer cells Lymphocytes Biological response modifier 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Böyum A (1968) Isolation of mononuclear cells and granulocytes from human blood. Skand J Clin Lab Invest 21:S77-S89Google Scholar
  2. Brunda MJ, Herberman RB, Holden HT (1980) Inhibition of murine natural killer cell activity by prostaglandins. J Immunol 124:2682–2687Google Scholar
  3. Cesario TC, Yousefi S, Carandang G (1989) The regulation of interferon production by aspirin, other inhibitors of the cyclooxygenase pathway and agents influencing calcium channel flux. Bull NY Acad Med 65:26–35Google Scholar
  4. Cosentino LM, Cathcart MK (1987) A multi-step scheme for obtaining CD16+ human natural killer cells. J Immunol Methods 103:195–204Google Scholar
  5. Droller MJ, Schneider MU, Perlmann P (1978) A possible role of prostaglandins in the inhibition of natural and antibody-dependent cell-mediated cytotoxicity against tumor cells. Cell Immunol 39:165–177Google Scholar
  6. Field WE, Ferguson FG, Reddanna P, Reddy CC (1988) The effect of selected arachidonic acid metabolites on natural killer cell activity. Prostaglandins 36:411–419Google Scholar
  7. Goodwin JS, Ceuppens J (1983) Regulation of the immune response by prostaglandins. J Clin Immunol 3:295–315Google Scholar
  8. Hial V, Horakova Z, Shaff R, Beaven MA (1976) Alteration of tumor growth by aspirin and indomethacin: studies with two transplantable tumors in mouse. Eur J Pharmacol 37:367–376Google Scholar
  9. Hockertz S, Schettler T, Rogalla K (1992) Effect of acetylsalicylic acid, ascorbate and ibuprofen on the macrophage system. Arzneim Forsch 42:1062–1068Google Scholar
  10. Hsia J, Sarin N, Oliver JH, Goldstein AL (1989a) Aspirin and thymosin increase interleukin-2 and interferon-gamma production by human peripheral blood lymphocytes. Immunopharmacology 17:167–173Google Scholar
  11. Hsia J, Simon GL, Higgins N, Goldstein AL, Hayden FG (1989b) Immune modulation by aspirin during experimental rhinovirus colds. Bull NY Acad Med 65:45–56Google Scholar
  12. Lynch NR, Castes M, Astoin M, Salomon JC (1978) Mechanism of inhibition of tumor growth by aspirin and indomethacin. Br J Cancer 38:503–512Google Scholar
  13. Oben JA, Forman JC (1988) A simple quantitative fluorimetric assay of in vitro phagocytosis in human neutrophils. J Immunol Methods 112:99–103Google Scholar
  14. Plescia OJ, Smith AH, Ginwich K (1975) Subversion of immune system by tumor cells role of prostaglandins. Proc Nat Acad Sci USA 72:1848–1851Google Scholar
  15. Rodriguez AB, Barriga C, De la Fuente M (1989) Effects of acetylsalicylic acid on the phagocytic function of human polymorphonuclear leukocytes in vitro. Gen Pharmacol 20:151–155Google Scholar
  16. Schenkelaars EJ, Bonta IL (1986) Cyclooxygenase inhibitors promote the leukotriene C4 induced release of β-glucuronidase from rat peritoneal macrophages: prostaglandin E2 Suppresses. Int J Immunopharmacol 8:305–311Google Scholar
  17. Schumacher K, Uhlenbruck G, Chaterjee BP, Steinhausen G, Vaith P, Van Mil A (1978) A new group of mitogenic lectins from invertebrate sources. Z Immun Forsch 154:62–74Google Scholar
  18. Taffet SM, Russell SW (1980) Macrophage-mediated tumor cell killing: Regulation of expression of cytolytic activity by prostaglandin E. J Immunol 126:424–427Google Scholar
  19. Thun MJ, Namboodiri MM, Heath CW (1991) Aspirin use and reduced risk of colon cancer. New Engl J Med 325:1593–1596Google Scholar
  20. Trofatter KF, Daniels A (1979) Interaction of human cells with prostaglandins and cyclic AMP modulators. J Immunol 122:1363–1370Google Scholar
  21. Uhlenbruck G, Van Mil A, Dreesbach K, Koch O (1982) Makrophagen und Phagozytose-Funktionstestes. Immun Infekt 10:122–129Google Scholar
  22. Valdez JC, Perdigon G (1991) Piroxicam indomethacin and aspirin action on a murine fibrosarcoma. Effects on tumor-associated and peritoneal macrophages. Clin Exp Immunol 86:315–321Google Scholar
  23. Voth R, Chmielarczyk W, Storch E, Kirchner H (1986) Induction of natural killer cell activity in mice by injection of indomethacin. Nat Immun Cell Growth Regul 5:317–324Google Scholar

Copyright information

© Springer-Verlag 1993

Authors and Affiliations

  • G. Uhlenbruck
    • 1
  • H. Lötzerich
    • 2
  • J. Bernhardt
    • 3
  • K. Rogalla
    • 4
  1. 1.Institut für ImmunbiologieUniversität KölnCologne 41Germany
  2. 2.Institut für Experimentelle MorphologieDeutsche Sporthochschule KölnCologneGermany
  3. 3.Institut für PharmakologieUniversität HamburgHamburgGermany
  4. 4.Pharmaforschungszentrum Bayer AGWuppertalGermany

Personalised recommendations